Vertex Pharmaceuticals Incorporated(VRTX)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
VRTX | 123.26 B | 28.84x | 7.80% | 35.51% | $16.84 | 24.20% | 0.10 | - | $507.92 | $362.50 |
950160.KQ | 5.19 T | - | - | - | - | - | - | - | $149000.00 | $35800.00 |
ABBV | 449.63 B | 124.75x | 12.40% | 5.79% | $2.04 | - | - | 2.75% | $255.99 | $178.57 |
AMGN | 197.69 B | 25.47x | 5.80% | 20.96% | $14.38 | 1.01% | 6.24 | 2.78% | $388.36 | $264.02 |
950220.KQ | 8.72 B | - | 38.82% | - | - | -71.12% | 0.20 | - | $7035.00 | $1249.00 |
Peer Valuation & Performance Analysis
Peer group analysis for Vertex Pharmaceuticals Incorporated (VRTX) compared to its primary competitors (including 950160.KQ, ABBV, AMGN) reveals distinct metrics. VRTX trades at a valuation discount relative to its competitors, with a P/E ratio of 28.8x versus the peer average of 75.1x (representing a 62% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, VRTX's revenue growth of 7.8% lags behind the peer average of 19.0%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 35.5% compared to the peer average of 13.4%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• VRTX ranks #2 in P/E ratio, #3 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $483.51 | $496.69 | $481.98 | $485.65 | 1,568,100 | +0.44% |
| 2026-07-16 | $480.00 | $487.30 | $476.25 | $486.03 | 1,370,800 | +1.26% |
| 2026-07-15 | $472.15 | $480.96 | $469.60 | $477.08 | 1,192,000 | +1.04% |
| 2026-07-14 | $481.29 | $481.29 | $473.18 | $476.31 | 1,093,600 | -1.03% |
| 2026-07-13 | $486.18 | $486.18 | $474.71 | $480.25 | 1,153,900 | -1.22% |
| 2026-07-10 | $498.15 | $498.91 | $484.33 | $485.39 | 1,430,200 | -2.56% |
| 2026-07-09 | $495.58 | $500.77 | $482.11 | $496.50 | 2,106,900 | +0.19% |
| 2026-07-08 | $523.04 | $525.81 | $498.14 | $498.43 | 2,287,000 | -4.71% |
| 2026-07-07 | $530.00 | $533.67 | $512.77 | $522.25 | 2,292,600 | -1.46% |
| 2026-07-06 | $526.67 | $529.99 | $512.34 | $529.59 | 1,513,300 | +0.55% |
| 2026-07-02 | $503.76 | $529.14 | $501.53 | $528.04 | 1,855,600 | +4.82% |
| 2026-07-01 | $502.71 | $502.71 | $494.80 | $498.01 | 1,444,300 | -0.93% |
| 2026-06-30 | $500.49 | $500.99 | $489.62 | $496.73 | 1,738,000 | -0.75% |
| 2026-06-29 | $495.83 | $499.87 | $487.62 | $499.65 | 2,055,700 | +0.77% |
| 2026-06-26 | $482.50 | $503.89 | $482.20 | $491.34 | 8,692,600 | +1.83% |